Substantial equivalence
A 510(k)-cleared device received an FDA substantial-equivalence determination for its specific indications and technology. It is not an FDA certificate.
Concept render, physical prototype, bench test, regulatory analogue and market authorisation are different things. This site keeps them separate.
Intended use and indications come first. They influence whether a product is a device, its classification and the route required for a named market. These notes are not a classification decision.
A 510(k)-cleared device received an FDA substantial-equivalence determination for its specific indications and technology. It is not an FDA certificate.
PMA-approved is the route-specific term for applicable Class III devices. Approval must never be borrowed from another product or used as a brand badge.
A De Novo request may be granted to create a new Class I or II device type when there is no legally marketed predicate. It is neither a 510(k) clearance nor a certificate.
Establishment registration or device listing does not denote approval, clearance or authorisation.
Cosmetics and their ingredients do not require FDA premarket approval, except color additives. They still must be safe for intended use and properly labeled.
FDA · Device determination ↗FDA · 510(k) ↗FDA · Approved terminology ↗FDA · Cosmetics authority ↗
Which framework applies is decided by intended use, risk and the target market — not by how a product looks or where a site files it. This section explains the frameworks; it is not a classification decision for any Beauty Charms concept.
CDRH guidance sets a compliance policy for low-risk products that promote a healthy lifestyle and are unrelated to diagnosing, curing, mitigating, preventing or treating a disease. It does not apply to cosmetics, drugs, foods or supplements, and the statutory carve-out it interprets is written for software functions. Whether a concept qualifies is a reviewed determination, never a self-declaration.
Most Class I and some Class II device types are exempt from 510(k). Exempt devices still fall under general controls such as establishment registration, device listing, labeling, quality system requirements and adverse-event reporting.
Under the FD&C Act, articles intended to cleanse, beautify or alter appearance are cosmetics; articles intended to diagnose, treat, mitigate or prevent disease, or to affect structure or function, are drugs or devices. One product can fall into more than one category at the same time.
The Modernization of Cosmetics Regulation Act of 2022 added obligations for cosmetic products, including facility registration, product listing, safety substantiation and adverse-event reporting. Carrier concepts on the cosmetic axis must be assessed there rather than borrowing the device vocabulary.
Intended use is established by the objective intent of the people who market the product — labeling, advertising and overall presentation. A website's own wording is part of that record, which is why claim language is frozen before publication here.
Indications for Use is the specific statement of the disease or condition a device is used for, and the target population. It appears in a cleared submission and is narrower than intended use. The two terms are not interchangeable.
FDA · General wellness policy ↗FDA · Class I & II exemptions ↗FDA · Cosmetic, drug, or both ↗FDA · MoCRA ↗
The current public record supports concept and experience language only. Medical benefit claims remain empty.
Carry, open, visual intent and intended ritual.
Must remain qualified as intended or targeted until product-specific evidence exists.
No diagnosis, treatment, cure, prevention or disease claim.
Beauty Charms display categories help users browse the site. They do not determine FDA Class I, II or III, product code, exemption or submission route.
A content and browsing taxonomy. “Functional-device concept” means the regulatory pathway is undetermined, not that certification is pending.
Requires qualified review and evidence for the exact product. Current status: not determined.
These are design questions, not proof of safety. Product-specific instructions can only be written after identity, output and materials are frozen.
Wavelength, irradiance, dose, session, eye exposure and thermal rise all remain product-level questions.
Output limits, current path, contact quality and contraindications are not yet validated.
Suction concepts may be stopped entirely if pressure limits, tissue risk and predictable misuse cannot be resolved.
Candidate silicone, plastics, metals, coatings and adhesives need product-specific contact, ageing and cleaning evaluation.
A reusable contact part needs a verified cleaning method, dry storage and replacement interval before public instructions are final.
Until a named reviewer and date exist, the page says so. An empty record is safer than a decorative seal.
Not frozen
Not selected
Concept visual only
Concept-only
G2 · Identity freeze
No publication approval recorded
Products shown are early design concepts. Images and motion studies communicate intent only. They do not establish physical performance, safety, regulatory classification, clearance, approval or certification.
READ G1—G7